Menu

K

Karius

Verified

Visit Website Connect with Founders

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

About Karius

Karius builds in the biotech category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Funding context: Khosla Ventures, $165M Series B in 2020

Recent milestones:

Karius appears in the 100Xfounder startup directory import feed.

Why it Matters

Karius matters because karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Funding Snapshot

Total Funding: $165.00MLast Round: Series B Khosla Ventures, $165M Series B in 2020All Rounds: 1

Series B | Khosla Ventures, $165M Series B in 2020

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Karius Team

Karius Team

Founder & CEO

Tech Stack

AWSReactPythonPostgreSQL

Last updated: April 17, 2026

Karius intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Biotech with comparable market signals.

N

NewLimit Team

View Company Compare Alternatives

RT

ROME Therapeutics

ROME Therapeutics Team

View Company Compare Alternatives

HF

Hoxton Farms Team

View Company Compare Alternatives

K

Kernel Team

View Company Compare Alternatives

S

Synchron Team

View Company Compare Alternatives

CL

Clear Labs Team

View Company Compare Alternatives

BL

BioAge Labs Team

View Company Compare Alternatives

CT

CAMP4 Therapeutics

CAMP4 Therapeutics Team

View Company Compare Alternatives

Discover Now

Newsroom and topic pages connected to Karius.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United States startup directory→United States startup news→Startups in United States→Biotech hub→Biotech startup list→Series B startups→Series B startup list→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Karius

Common questions people ask about this profile.

What is Karius?

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Who founded Karius?

Karius is associated with Karius Team on 100Xfounder.

Where is Karius located?

Karius is listed in San Francisco Bay Area, California, USA.

What stage is Karius in?

Karius is currently mapped to Series B. Funding context: Khosla Ventures, $165M Series B in 2020

What is the latest funding round of Karius?

Karius's latest tracked round is Series B Khosla Ventures, $165M Series B in 2020. Total tracked rounds: 1.

Is Karius hiring now?

Karius hiring status: Open Roles.

What technologies does Karius use?

Karius is associated with AWS, React, Python, and PostgreSQL.

Is Karius verified on 100Xfounder?

Yes. Karius is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with Karius founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.